NCT02932007View on ClinicalTrials.gov

Chloroquine for Patients With Symptomatic Persistent Atrial Fibrillation: A Prospective Pilot Study

PHASE2RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 28, 2017

Primary Completion Date

March 31, 2020

Study Completion Date

September 30, 2020

Conditions
Atrial Fibrillation
Interventions
DRUG

Chloroquine Phosphate

Two tablets of study drug are to be taken on the day of study drug initiation and the next day, followed by one tablet each day for the next 12 days. Study drug to be orally administered and taken with food.

Trial Locations (1)

33606

RECRUITING

University of South Florida, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER